(E)-thiamethoxam increases expression ISO RGD:1552792 6480464 Thiamethoxam results in increased expression of CXCL5 mRNA CTD PMID:33533595 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:1552792 6480464 Dinitrochlorobenzene results in increased expression of CXCL5 mRNA CTD PMID:19647056 1-nitropyrene decreases expression ISO RGD:1345336 6480464 1-nitropyrene results in decreased expression of CXCL6 mRNA CTD PMID:19428942 17alpha-ethynylestradiol multiple interactions ISO RGD:1552792 6480464 [Ethinyl Estradiol co-treated with ESR1 protein] inhibits the reaction [IL1B protein results in increased expression of CXCL5 mRNA], Ethinyl Estradiol inhibits the reaction [IL1B protein results in increased expression of CXCL5 mRNA] CTD PMID:12072388 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of CXCL5 mRNA CTD PMID:15212814 , PMID:15834898 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of CXCL6 mRNA CTD PMID:26496021 17beta-estradiol multiple interactions ISO RGD:1552792 6480464 Estradiol inhibits the reaction [IL1B protein results in increased expression of CXCL5 mRNA] CTD PMID:12072388 17beta-estradiol increases expression ISO RGD:1552792 6480464 Estradiol results in increased expression of CXCL5 mRNA CTD PMID:19484750 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CXCL5 mRNA, Tetrachlorodibenzodioxin results in increased expression of CXCL6 mRNA CTD PMID:15644576 , PMID:19692669 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1552792 6480464 [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA] more ... CTD PMID:15667827 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1552792 6480464 Tetrachlorodibenzodioxin results in increased expression of CXCL5 mRNA CTD PMID:16054899 more ... 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:1552792 6480464 Trinitrobenzenesulfonic Acid results in increased expression of CXCL5 mRNA CTD PMID:17982090 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:1345336 6480464 2 more ... CTD PMID:26705709 2-amino-2-deoxy-D-glucopyranose multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of CXCL5 mRNA] CTD PMID:17109745 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:19692669 3,4-dichloroaniline increases expression EXP 6480464 3, 4-dichloroaniline results in increased expression of CXCL5 mRNA CTD PMID:24172598 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1552792 6480464 [Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA more ... CTD PMID:16054899 , PMID:23503329 3-methylcholanthrene multiple interactions ISO RGD:1552792 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CXCL5 mRNA CTD PMID:23519560 4,4'-sulfonyldiphenol decreases expression ISO RGD:1345336 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of CXCL6 mRNA CTD PMID:27685785 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO RGD:1552792 6480464 Oxazolone results in increased expression of CXCL5 mRNA CTD PMID:19647056 4-hydroxyphenyl retinamide increases expression ISO RGD:1552792 6480464 Fenretinide results in increased expression of CXCL5 mRNA CTD PMID:16467112 4-nitroquinoline N-oxide increases expression ISO RGD:1552792 6480464 4-Nitroquinoline-1-oxide results in increased expression of CXCL5 mRNA CTD PMID:27148699 7,12-dimethyltetraphene increases expression ISO RGD:1552792 6480464 9 more ... CTD PMID:32553695 7,12-dimethyltetraphene multiple interactions ISO RGD:1552792 6480464 [9 more ... CTD PMID:32553695 8'-apo-beta,psi-caroten-8'-al increases expression ISO RGD:1345336 6480464 apocarotenal results in increased expression of CXCL6 mRNA CTD PMID:17034753 acetylsalicylic acid increases expression EXP 6480464 Aspirin results in increased expression of CXCL5 mRNA CTD PMID:12800193 aldehydo-D-glucosamine multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of CXCL5 mRNA] CTD PMID:17109745 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CXCL6 mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:1345336 6480464 Antirheumatic Agents results in decreased expression of CXCL6 mRNA CTD PMID:24449571 Aroclor 1254 decreases expression ISO RGD:1552792 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of CXCL5 mRNA CTD PMID:23650126 arsenite(3-) increases expression ISO RGD:1552792 6480464 arsenite results in increased expression of CXCL5 mRNA CTD PMID:18929588 arsenite(3-) multiple interactions ISO RGD:1552792 6480464 TRP53 protein affects the reaction [arsenite results in increased expression of CXCL5 mRNA] CTD PMID:18929588 asperentin decreases expression ISO RGD:1552792 6480464 cladosporin results in decreased expression of CXCL5 mRNA CTD PMID:19818335 benzalkonium chloride increases expression ISO RGD:1552792 6480464 Benzalkonium Compounds results in increased expression of CXCL5 mRNA, Benzalkonium Compounds results in increased expression of CXCL5 protein CTD PMID:30171875 , PMID:30517752 benzalkonium chloride multiple interactions ISO RGD:1552792 6480464 [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of CXCL5 mRNA CTD PMID:30171875 benzo[a]pyrene increases methylation ISO RGD:1345336 6480464 Benzo(a)pyrene results in increased methylation of CXCL6 5' UTR CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:1552792 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CXCL5 mRNA, [Benzo(a)pyrene results in increased activity of AHR protein] which results in increased expression of CXCL5 mRNA CTD PMID:27858113 , PMID:32553695 benzo[a]pyrene increases expression ISO RGD:1552792 6480464 Benzo(a)pyrene metabolite results in increased expression of CXCL5 mRNA CTD PMID:32553695 benzo[b]fluoranthene multiple interactions ISO RGD:1552792 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CXCL5 mRNA CTD PMID:27858113 benzo[b]fluoranthene decreases expression ISO RGD:1552792 6480464 benzo(b)fluoranthene results in decreased expression of CXCL5 mRNA CTD PMID:26377693 beta-carotene increases expression ISO RGD:1345336 6480464 beta Carotene results in increased expression of CXCL6 mRNA CTD PMID:17034753 beta-D-glucosamine multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of CXCL5 mRNA] CTD PMID:17109745 beta-naphthoflavone multiple interactions ISO RGD:1552792 6480464 IL1B protein promotes the reaction [beta-Naphthoflavone results in increased expression of CXCL5 mRNA] CTD PMID:28973351 beta-naphthoflavone increases expression ISO RGD:1552792 6480464 beta-Naphthoflavone results in increased expression of CXCL5 mRNA CTD PMID:28973351 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of CXCL6 mRNA CTD PMID:26496021 bisphenol A multiple interactions ISO RGD:1345336 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of CXCL6 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:1345336 6480464 bisphenol A results in increased expression of CXCL6 mRNA CTD PMID:28736254 bisphenol A decreases expression ISO RGD:1345336 6480464 bisphenol A results in decreased expression of CXCL6 mRNA CTD PMID:27685785 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CXCL6 mRNA CTD PMID:25181051 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of CXCL5 mRNA CTD PMID:20471445 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of CXCL6 promoter CTD PMID:22457795 cadmium dichloride multiple interactions ISO RGD:1345336 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased secretion of CXCL6 protein], Cadmium Chloride results in increased expression of and results in increased secretion of CXCL6 protein CTD PMID:26138014 capsaicin increases expression EXP 6480464 Capsaicin results in increased expression of CXCL5 protein CTD PMID:22150557 capsaicin multiple interactions EXP 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CXCL5 protein] more ... CTD PMID:22150557 carbon nanotube increases expression ISO RGD:1345336 6480464 Nanotubes, Carbon results in increased expression of CXCL6 mRNA CTD PMID:29348435 carbon nanotube increases expression ISO RGD:1552792 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:26839332 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon results in increased expression of CXCL5 mRNA CTD PMID:19836432 , PMID:24911292 ceric oxide multiple interactions ISO RGD:1552792 6480464 ceric oxide promotes the reaction [Antigens, Dermatophagoides results in increased expression of CXCL5 mRNA] CTD PMID:29792201 chloroprene increases expression ISO RGD:1552792 6480464 Chloroprene results in increased expression of CXCL5 mRNA CTD PMID:23125180 choline multiple interactions ISO RGD:1552792 6480464 [Dietary Fats co-treated with Choline deficiency] results in increased expression of CXCL5 protein more ... CTD PMID:20938992 , PMID:29246445 chrysene multiple interactions ISO RGD:1552792 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CXCL5 mRNA CTD PMID:27858113 chrysene decreases expression ISO RGD:1552792 6480464 chrysene results in decreased expression of CXCL5 mRNA CTD PMID:26377693 cobalt atom multiple interactions ISO RGD:1552792 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA, TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA] CTD PMID:23503329 crocidolite asbestos increases expression ISO RGD:1345336 6480464 Asbestos, Crocidolite results in increased expression of CXCL6 mRNA CTD PMID:24160326 , PMID:25757056 crocidolite asbestos decreases expression ISO RGD:1552792 6480464 Asbestos, Crocidolite results in decreased expression of CXCL5 mRNA CTD PMID:26839332 cyclophosphamide increases expression ISO RGD:1552792 6480464 Cyclophosphamide results in increased expression of CXCL5 mRNA CTD PMID:15331540 cyclosporin A decreases expression ISO RGD:1345336 6480464 Cyclosporine results in decreased expression of CXCL6 mRNA CTD PMID:22147139 , PMID:27989131 dexamethasone decreases expression ISO RGD:1345336 6480464 Dexamethasone results in decreased expression of CXCL6 mRNA CTD PMID:25047013 dexamethasone multiple interactions ISO RGD:1552792 6480464 [Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA more ... CTD PMID:16054899 , PMID:23503329 dextran sulfate increases expression ISO RGD:1552792 6480464 Dextran Sulfate results in increased expression of CXCL5 mRNA CTD PMID:19645018 dextran sulfate multiple interactions ISO RGD:1552792 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CXCL5 mRNA CTD PMID:29950665 dibenz[a,h]anthracene decreases expression ISO RGD:1552792 6480464 1 more ... CTD PMID:26377693 diethyl malate affects expression ISO RGD:1552792 6480464 diethyl malate affects the expression of CXCL5 mRNA CTD PMID:24814887 diethylstilbestrol decreases expression ISO RGD:1552792 6480464 Diethylstilbestrol results in decreased expression of CXCL5 mRNA CTD PMID:15171707 dioxygen multiple interactions ISO RGD:1552792 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CXCL5 mRNA CTD PMID:30529165 diuron increases expression EXP 6480464 Diuron metabolite results in increased expression of CXCL5 mRNA CTD PMID:24172598 dorsomorphin multiple interactions ISO RGD:1345336 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1345336 6480464 Doxorubicin results in decreased expression of CXCL6 mRNA CTD PMID:16404146 , PMID:29803840 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of CXCL6 mRNA CTD PMID:18035473 folic acid multiple interactions ISO RGD:1552792 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CXCL5 mRNA CTD PMID:20938992 folic acid decreases expression ISO RGD:1345336 6480464 Folic Acid results in decreased expression of CXCL6 mRNA CTD PMID:28752528 formaldehyde increases expression ISO RGD:1345336 6480464 Formaldehyde results in increased expression of CXCL6 mRNA CTD PMID:28937961 fulvestrant multiple interactions ISO RGD:1345336 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of CXCL6 gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of CXCL5 mRNA CTD PMID:27387713 Genipin multiple interactions ISO RGD:1552792 6480464 genipin inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL5 mRNA] CTD PMID:22687549 genistein multiple interactions ISO RGD:1552792 6480464 Genistein inhibits the reaction [IL1B protein results in increased expression of CXCL5 mRNA] CTD PMID:12072388 graphene oxide increases expression ISO RGD:1552792 6480464 graphene oxide results in increased expression of CXCL5 mRNA, graphene oxide results in increased expression of CXCL6 mRNA CTD PMID:33227293 GW 4064 increases expression ISO RGD:1552792 6480464 GW 4064 results in increased expression of CXCL5 mRNA CTD PMID:26655953 hexachlorobenzene increases expression EXP 6480464 Hexachlorobenzene results in increased expression of CXCL5 mRNA CTD PMID:15159207 hydrogen peroxide decreases secretion ISO RGD:1345336 6480464 Hydrogen Peroxide results in decreased secretion of CXCL6 protein CTD PMID:33491125 hydrogen peroxide increases expression ISO RGD:1345336 6480464 Hydrogen Peroxide results in increased expression of CXCL6 mRNA CTD PMID:32949572 Indeno[1,2,3-cd]pyrene decreases expression ISO RGD:1552792 6480464 indeno(1 more ... CTD PMID:26377693 L-ascorbic acid decreases expression ISO RGD:1345336 6480464 Ascorbic Acid results in decreased expression of CXCL6 mRNA CTD PMID:19932582 L-ascorbic acid increases expression ISO RGD:1345336 6480464 Ascorbic Acid deficiency results in increased expression of CXCL6 mRNA CTD PMID:19932582 L-methionine multiple interactions ISO RGD:1552792 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CXCL5 mRNA CTD PMID:20938992 lipopolysaccharide increases secretion ISO RGD:1552792 6480464 Lipopolysaccharides results in increased secretion of CXCL5 protein CTD PMID:32800949 lipopolysaccharide multiple interactions ISO RGD:1552792 6480464 2'-hydroxyflavanone inhibits the reaction [Lipopolysaccharides results in increased secretion of CXCL5 protein], genipin inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL5 mRNA] CTD PMID:22687549 , PMID:32800949 lipopolysaccharide increases expression ISO RGD:1552792 6480464 Lipopolysaccharides results in increased expression of CXCL5 mRNA CTD PMID:21356202 , PMID:22687549 manganese atom increases expression ISO RGD:1345336 6480464 Manganese results in increased expression of CXCL6 mRNA CTD PMID:17175027 manganese(0) increases expression ISO RGD:1345336 6480464 Manganese results in increased expression of CXCL6 mRNA CTD PMID:17175027 manganese(II) chloride increases expression ISO RGD:1345336 6480464 manganese chloride results in increased expression of CXCL6 mRNA CTD PMID:17175027 mercury atom increases expression EXP 6480464 Mercury results in increased expression of CXCL5 mRNA CTD PMID:12730625 mercury(0) increases expression EXP 6480464 Mercury results in increased expression of CXCL5 mRNA CTD PMID:12730625 methylmercury chloride increases expression ISO RGD:1552792 6480464 methylmercuric chloride results in increased expression of CXCL5 mRNA CTD PMID:24213012 microcystin-LR multiple interactions EXP 6480464 [Dietary Fats co-treated with Cholesterol, Dietary co-treated with cyanoginosin LR] results in increased expression of CXCL5 protein CTD PMID:34740672 mycophenolic acid decreases expression ISO RGD:1552792 6480464 Mycophenolic Acid results in decreased expression of CXCL5 mRNA CTD PMID:19818335 mycophenolic acid increases expression ISO RGD:1552792 6480464 Mycophenolic Acid results in increased expression of CXCL5 mRNA CTD PMID:19818335 mycotoxin increases expression ISO RGD:1552792 6480464 Mycotoxins results in increased expression of CXCL5 mRNA CTD PMID:19818335 mycotoxin affects expression ISO RGD:1552792 6480464 Mycotoxins affects the expression of CXCL5 mRNA CTD PMID:21356202 mycotoxin decreases expression ISO RGD:1552792 6480464 Mycotoxins results in decreased expression of CXCL5 mRNA CTD PMID:19818335 N-acetyl-L-cysteine multiple interactions ISO RGD:1345336 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased secretion of CXCL6 protein] CTD PMID:26138014 N-Acetyl-S-(1,2-dichlorovinyl)-cysteine affects expression ISO RGD:1345336 6480464 S-1, 2-dichlorovinyl-N-acetylcysteine affects the expression of CXCL6 mRNA CTD PMID:16844155 naproxen multiple interactions EXP 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CXCL5 protein], Naproxen inhibits the reaction [Capsaicin results in increased expression of CXCL5 protein] CTD PMID:22150557 neoechinulin A decreases expression ISO RGD:1552792 6480464 neoechinulin A results in decreased expression of CXCL5 mRNA CTD PMID:19818335 neoechinulin A increases expression ISO RGD:1552792 6480464 neoechinulin A results in increased expression of CXCL5 mRNA CTD PMID:21356202 nickel atom increases expression ISO RGD:1345336 6480464 Nickel results in increased expression of CXCL6 mRNA CTD PMID:24768652 , PMID:25583101 nickel atom multiple interactions ISO RGD:1552792 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA, TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA] CTD PMID:23503329 nickel dichloride increases expression ISO RGD:1345336 6480464 nickel chloride results in increased expression of CXCL6 mRNA CTD PMID:17312168 nickel sulfate multiple interactions ISO RGD:1345336 6480464 nickel sulfate promotes the reaction [macrophage stimulatory lipopeptide 2 results in increased expression of CXCL6 mRNA] CTD PMID:18832182 oleanolic acid increases expression EXP 6480464 Oleanolic Acid results in increased expression of CXCL5 mRNA CTD PMID:18706400 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CXCL6 mRNA CTD PMID:25729387 ozone increases expression ISO RGD:1345336 6480464 Ozone results in increased expression of CXCL6 mRNA CTD PMID:31476115 ozone multiple interactions ISO RGD:1552792 6480464 IL4 protein affects the reaction [Ozone results in increased expression of CXCL5 mRNA] CTD PMID:18417511 ozone increases expression ISO RGD:1552792 6480464 Ozone results in increased expression of CXCL5 mRNA, Ozone results in increased expression of CXCL5 protein CTD PMID:14754758 more ... p-chloromercuribenzoic acid decreases expression ISO RGD:1345336 6480464 p-Chloromercuribenzoic Acid results in decreased expression of CXCL6 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1345336 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CXCL6 mRNA CTD PMID:27188386 p-menthan-3-ol multiple interactions EXP 6480464 [Tobacco Smoke Pollution co-treated with Menthol] results in increased expression of and results in increased secretion of CXCL6 protein CTD PMID:27818348 paracetamol increases expression ISO RGD:1345336 6480464 Acetaminophen results in increased expression of CXCL6 mRNA CTD PMID:26690555 paracetamol multiple interactions ISO RGD:1552792 6480464 MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of CXCL5 mRNA] CTD PMID:18700144 paracetamol affects expression ISO RGD:1552792 6480464 Acetaminophen affects the expression of CXCL5 mRNA CTD PMID:17562736 phenylephrine decreases expression EXP 6480464 Phenylephrine results in decreased expression of CXCL5 mRNA CTD PMID:18158353 phenylmercury acetate decreases expression ISO RGD:1345336 6480464 Phenylmercuric Acetate results in decreased expression of CXCL6 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1345336 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CXCL6 mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1345336 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CXCL6 mRNA CTD PMID:16979875 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1552792 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CXCL5 mRNA CTD PMID:23519560 pioglitazone multiple interactions ISO RGD:1552792 6480464 [N-nitroso-tris-chloroethylurea co-treated with Pioglitazone] results in increased expression of CXCL5 mRNA CTD PMID:27935865 pirinixic acid multiple interactions ISO RGD:1552792 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CXCL5 mRNA CTD PMID:19710929 progesterone affects expression ISO RGD:1552792 6480464 Progesterone affects the expression of CXCL5 mRNA CTD PMID:17251523 quartz increases expression EXP 6480464 Quartz results in increased expression of CXCL5 mRNA, Quartz results in increased expression of CXCL6 mRNA CTD PMID:19836432 , PMID:32976597 quartz multiple interactions EXP 6480464 Tobacco Smoke Pollution promotes the reaction [Quartz results in increased expression of CXCL6 mRNA] CTD PMID:32976597 raloxifene multiple interactions ISO RGD:1552792 6480464 Raloxifene Hydrochloride inhibits the reaction [IL1B protein results in increased expression of CXCL5 mRNA] CTD PMID:12072388 resveratrol decreases expression ISO RGD:1345336 6480464 resveratrol results in decreased expression of CXCL6 mRNA CTD PMID:23224687 resveratrol decreases expression ISO RGD:1552792 6480464 Resveratrol results in decreased expression of CXCL5 mRNA CTD PMID:25280562 resveratrol multiple interactions ISO RGD:1345336 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of CXCL6 mRNA CTD PMID:23557933 ritonavir decreases expression ISO RGD:1345336 6480464 Ritonavir results in decreased expression of CXCL6 CTD PMID:26626330 SB 431542 multiple interactions ISO RGD:1345336 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 serpentine asbestos increases expression ISO RGD:1345336 6480464 Asbestos, Serpentine results in increased expression of CXCL6 mRNA CTD PMID:24160326 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of CXCL5 mRNA CTD PMID:22431001 silicon dioxide increases expression ISO RGD:1552792 6480464 Silicon Dioxide results in increased expression of CXCL5 mRNA CTD PMID:23221170 , PMID:29341224 simvastatin decreases expression EXP 6480464 Simvastatin results in decreased expression of CXCL5 mRNA CTD PMID:16414398 sodium arsenite increases expression ISO RGD:1345336 6480464 sodium arsenite results in increased expression of CXCL6 mRNA CTD PMID:28595984 , PMID:34032870 sodium arsenite decreases expression ISO RGD:1552792 6480464 sodium arsenite results in decreased expression of CXCL5 mRNA CTD PMID:21911445 sodium fluoride decreases expression ISO RGD:1552792 6480464 Sodium Fluoride results in decreased expression of CXCL5 mRNA CTD PMID:21340527 sterigmatocystin decreases expression ISO RGD:1552792 6480464 Sterigmatocystin results in decreased expression of CXCL5 mRNA CTD PMID:19818335 , PMID:21356202 succimer multiple interactions ISO RGD:1552792 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CXCL5 mRNA CTD PMID:26378955 sumatriptan multiple interactions EXP 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CXCL5 protein], Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CXCL5 protein] CTD PMID:22150557 taurocholic acid multiple interactions ISO RGD:1552792 6480464 EGR1 promotes the reaction [Taurocholic Acid results in increased expression of CXCL5 mRNA] CTD PMID:21224055 taurocholic acid increases expression ISO RGD:1552792 6480464 Taurocholic Acid results in increased expression of CXCL5 mRNA CTD PMID:21224055 tetrachloromethane increases expression ISO RGD:1552792 6480464 Carbon Tetrachloride results in increased expression of CXCL5 mRNA, Carbon Tetrachloride results in increased expression of CXCL5 protein CTD PMID:17484886 , PMID:29987408 tetraphene multiple interactions ISO RGD:1552792 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CXCL5 mRNA CTD PMID:27858113 thiamethoxam increases expression ISO RGD:1552792 6480464 Thiamethoxam results in increased expression of CXCL5 mRNA CTD PMID:33533595 titanium dioxide increases expression ISO RGD:1552792 6480464 titanium dioxide results in increased expression of CXCL5 mRNA CTD PMID:21259345 , PMID:23557971 titanium dioxide multiple interactions ISO RGD:1552792 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CXCL5 mRNA CTD PMID:29950665 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of CXCL5 mRNA CTD PMID:30012374 toluene 2,4-diisocyanate increases expression ISO RGD:1552792 6480464 Toluene 2, 4-Diisocyanate results in increased expression of CXCL5 mRNA CTD PMID:19647056 topotecan increases expression EXP 6480464 Topotecan results in increased expression of CXCL6 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CXCL6 mRNA CTD PMID:25729387 trichostatin A increases expression ISO RGD:1345336 6480464 trichostatin A results in increased expression of CXCL6 mRNA CTD PMID:24935251 valproic acid affects expression ISO RGD:1345336 6480464 Valproic Acid affects the expression of CXCL6 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:1345336 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CXCL6 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1345336 6480464 Valproic Acid results in increased expression of CXCL6 mRNA CTD PMID:23179753 more ... valproic acid decreases methylation ISO RGD:1345336 6480464 Valproic Acid results in decreased methylation of CXCL6 gene CTD PMID:29154799 valproic acid decreases expression ISO RGD:1345336 6480464 Valproic Acid results in decreased expression of CXCL6 mRNA CTD PMID:29154799 XL147 multiple interactions ISO RGD:1552792 6480464 [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CXCL5 mRNA CTD PMID:27935865 zinc atom multiple interactions ISO RGD:1345336 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CXCL6 mRNA CTD PMID:16979875 zinc atom increases expression EXP 6480464 Zinc deficiency results in increased expression of CXCL5 mRNA, Zinc deficiency results in increased expression of CXCL5 protein CTD PMID:22689922 zinc atom multiple interactions ISO RGD:1552792 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA, TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA] CTD PMID:23503329 zinc dichloride decreases expression ISO RGD:1345336 6480464 zinc chloride results in decreased expression of CXCL6 mRNA CTD PMID:19428942 zinc(0) multiple interactions ISO RGD:1345336 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CXCL6 mRNA CTD PMID:16979875 zinc(0) multiple interactions ISO RGD:1552792 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA, TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CXCL5 mRNA] CTD PMID:23503329 zinc(0) increases expression EXP 6480464 Zinc deficiency results in increased expression of CXCL5 mRNA, Zinc deficiency results in increased expression of CXCL5 protein CTD PMID:22689922